North China Pharmaceutical announced that the company and its subsidiaries have a total of 80 varieties and 150 product specifications of drugs entered the “National Essential Drug Catalogue”. There are 6 varieties newly added to the national drug catalogue, namely cefixime capsules, propofol fumarate tenofovir tablets, roxastat capsules, human granulocyte stimulating factor injections, tacrolimus capsules, and meccobalamin tablets. Seven additional dosage forms or specifications have been added, including injectable penicillin sodium 2.4 g, etc. Entering the basic drug catalogue this time will help expand the scale of the company's related products in the primary care market and have a positive impact on market expansion and long-term development.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.